GlassScriptPhysician profile
Josh D Davis
NPI 1659396828
$658.49
in general payments reported to CMS, 2019-2025
8 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.78 · 2020: $70.27 · 2021: $113 · 2022: $59.91 · 2023: $107 · 2024: $14.75 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $243.01 | 2020-2022 | |
| Biosense Webster, INC. | $163.20 | 2025 | Carto 3 |
| Volta Medical INC | $106.84 | 2023 | Vx1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.25 | 2024-2025 | Xifaxan, Trulance |
| Avanir Pharmaceuticals, INC. | $35.73 | 2019 | |
| Ethicon US, LLC | $32.41 | 2025 | Echelon; Endopath |
| Zyla Life Sciences, INC. | $21.96 | 2019 | |
| Genentech USA, INC. | $16.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josh Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.